GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Rejuvel Bio-Sciences NUUU · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2014

Revenue

$94,096

FY2014FY2014

Net income

−$352,865

FY2014FY2014

Free cash flow

−$527,120

FY2014FY2014

Shareholders' equity

−$833,434

FY2014FY2014

Income statement

Fiscal years

FY2014
Revenue$94,096
Gross profit$10,792
Research and development$7,000
Operating income−$687,205
Net income−$352,865
Diluted earnings per share-0.01

Balance sheet

At each fiscal year end

FY2014
Total assets$104,728
Cash and short-term investments$39,501
Total liabilities$938,162
Debt$157,068
Shareholders' equity−$833,434
Shares outstanding30m

Cash flow

Fiscal years

FY2014
Cash from operations−$493,785
Capital spending−$33,335
Free cash flow−$527,120

Latest quarters

By quarter end

Sept 2015Jun 2015Mar 2015Dec 2014Sept 2014Jun 2014Mar 2014Dec 2013
Revenue$50,408$36,145$70,356$30,419$18,353$43,056$2,268$4,313
Gross profit$40,176$31,271$61,183−$43,823$18,185$37,082−$652$5,532
Operating income−$235,582−$573,694−$210,962−$239,912−$192,592−$125,321−$129,380−$72,103
Net income−$327,512−$628,002−$244,807$148,297$175,199$1.7m−$2.4m−$154,403
Diluted earnings per share-0.01-0.01-0.000.000.010.06-0.08-0.00
Total assets$134,433$260,464$230,081$104,728$344,267$289,972$335,744$200,430
Cash and short-term investments$877$22,798$51,186—$198,417$179,634$225,312$64,580
Debt$361,655$250,411$161,416$427,815$157,068$77,401$87,789$227,428
Shareholders' equity−$1.6m−$1.3m−$932,280−$833,434−$697,703−$1.1m−$3.0m−$948,860

Growth per year

Compound annual rate

3 years5 years10 years
Revenue297.3%——
Operating income44.5%205.1%—
Net income15.7%167.0%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin24.4%26.1%——
Operating margin-835.5%-1368.2%——
Net margin-733.5%-1373.2%——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return900%0%-90%0%679%45875100%4700%12700%170567%1287%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.